![](/img/cover-not-exists.png)
Differential methylation of a CpG site in the CD95-ligand promoter predicts the response to therapy with APG101 in glioblastoma
Gieffers, C., Merz, C., Sykora, J., Kunz, C., Thiemann, M., Wiestler, B., Wick, W., Fricke, H.Volume:
61
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)61707-0
Date:
July, 2016
File:
PDF, 60 KB
english, 2016